NPCEVSSLS• Today (Normalized)
NPCE vs SLS (Neuropace Inc. vs SELLAS Life Sciences Group Inc.)
Showing Closing Date Range from Sep, 10 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NPCE Performance $14.04
+1.23%
Neuropace Inc.
Normalized Baseline0.00%
SLS Performance $11.55
-14.38%
SELLAS Life Sciences Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin NPCE LEADS
+15.61%
NPCE outperforming by 15.61%
NPCESLS
Spread TrajectoryToday (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NPCE SLS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(2 dates)
| Date | NPCE Price | NPCE Gain (%) | SLS Price | SLS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $14.04 | +1.23% | $11.55 | -14.38% | +15.61% |
| Sep 10, 2026 | $13.87 | +0.00% | $13.49 | +0.00% | +0.00% |